Jincheng Pharmaceutical (300233.SZ): Bisoprolol Fumarate Tablets Obtained Drug Registration Certificate

Zhitong Finance APP News, Jincheng Pharmaceutical (300233.SZ) announced that its wholly-owned subsidiary Shanghai Jincheng Suzhi Pharmaceutical Co., Ltd. (hereinafter referred to as "Jincheng Suzhi") recently received the "Drug Registration Certificate" for Bisoprolol Fumarate Tablets issued by the National Medical Products Administration. Bisoprolol Fumarate Tablets is a highly selective 1-adrenergic receptor blocker (cardioselective), used for hypertension, coronary heart disease (angina pectoris), and chronic stable heart failure with reduced left ventricular systolic function (ejection fraction 35%).